Background
Evidence has been emerging that anxiety disorders are associated with several physical health conditions. We used the first community survey, which assessed physical conditions based on physician assessment and included standardized diagnostic assessment of mental disorders by trained health professionals, to examine the relationship between anxiety disorders and physical conditions.
Methods
The German Health Survey (N = 4181; response rate, 87.6%; ages 18-65 years) used the Composite International Diagnostic Interview to assess Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition mood, substance use, and anxiety disorders (panic disorder, social phobia, specific phobia, generalized anxiety disorder, agoraphobia, obsessive-compulsive disorder) and a standardized medical interview supplemented by laboratory data to assess a broad range of physical conditions. The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) was used to measure health-related quality of life. Number of days of role impairment was used to measure past 30-day disability.
Results
After adjusting for sociodemographic factors and other common mental disorders, the presence of an anxiety disorder was significantly associated with thyroid disease, respiratory disease, gastrointestinal disease, arthritis, migraine headaches, and allergic conditions (adjusted odds ratios between 1.39 and 2.12; P<.05). Compared with physical disorders alone, the presence of comorbid anxiety disorder with 1 or more physical disorders was associated with poorer physical component scores on the SF-36 (adjusted mean scores for physical condition alone and physical condition with anxiety disorder, 48.50 and 45.86, respectively; P<.001) and past 30-day disability due to physical problems (adjusted odds ratio, 1.69; 95% confidence interval, 1.20-2.37).
Conclusion
Anxiety disorders are independently associated with several physical conditions in the community, and this comorbidity is significantly associated with poor quality of life and disability.
The negative impact of comorbidity of depression with physical illness has been well documented,1-4 and evidence has been emerging to show that anxiety disorders are associated with several physical health problems.5-15 For instance, phobic anxiety symptoms at baseline have been linked to sudden cardiac death.16-18 Clinical studies of individuals with specific physical illnesses (thyroid disease,19 cardiac disease,20-22 cancer,23 hypertension,24 diabetes,4,25 autoimmune diseases,26,27 peptic ulcer disease,28 and asthma13,29-32) have noted higher than expected levels of anxiety disorders among patients seeking treatment for physical conditions.33 Similarly, epidemiologic studies8-10,14,34-38 have found a positive association between the presence of anxiety disorder diagnoses and self-reported physical disorders.
Although evidence is mounting that anxiety disorders are often comorbid with physical disorders, 4 specific limitations of the current literature on this topic exist. First, the association between anxiety disorders and physical disorders found in clinical samples may be limited by sampling biases.39,40 Second, although epidemiologic samples reduce the likelihood of sampling bias, most of these studies have used self-report diagnosis of physical health conditions.41,42 Since individuals with anxiety disorders are more likely to report physical symptoms, it is possible that there may be a self-report bias of physical health conditions among individuals with anxiety disorders.43 Third, most epidemiologic studies have used lay interviewers to diagnose mental disorders rather than trained health professionals. Fourth, findings have been discrepant on the relationship between comorbidity of anxiety disorders and physical conditions with disability and quality of life. Some primary care sample studies44-46 have found that anxiety symptoms and anxiety disorders are associated with excess disability among primary care patients with physical health problems, whereas others have found that the associated disability was either minimal47 or due to comorbidity with other mental disorders.48 It remains uncertain whether the comorbidity of anxiety disorders with physical health problems is associated with functional impairments.
To address these limitations, we used the German Health Survey (GHS) to examine the relationship between anxiety disorders and physical illness. The GHS is the first survey to assign Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) mental disorder diagnoses using the highly reliable Composite International Diagnostic Interview and to use physician-based diagnosis of physical health conditions by interview, physical examination, and laboratory assessment.41,49 In addition, the GHS included a comprehensive assessment of functional status: (1) the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36),50 which is a highly reliable, widely used measure of health-related quality of life, and (2) past 30-day role impairment due to physical and emotional problems.
We had 2 specific objectives for the current study. First, we examined whether there were unique associations between the presence of an anxiety disorder with particular physical conditions. Second, we examined whether the comorbidity of anxiety and physical health problems was independently associated with poor quality of life and disability even after adjusting for potential confounding factors (eg, overall burden of physical illness).
The GHS was based on a stratified, multistage, cross-sectional, nationally representative sample of individuals, aged 18 to 79 years, from the noninstitutionalized population of Germany.41,51,52 The survey was approved by the institutional review board of the Robert Koch Institute (Berlin, Germany). A detailed description of the survey design is available elsewhere.10,41,49
In summary, all participants provided written informed consent. Data were collected between 1997 and 1999. The GHS had 2 components: the core survey (N = 7124; 61.5% response rate) and the mental health supplement (N = 4181; 87.6% response rate).41 The responders and nonresponders did not differ significantly by age, sex, and self-reported health status on the core survey.41
Assessment of Physical Conditions
The GHS assessed physical conditions based on a combination of 3 methods: (1) a self-report questionnaire asking about the presence of 44 physical conditions, (2) a standardized computer-assisted medical interview by a general practice physician, and (3) anthropometric blood pressure measurements, as well as collection of blood and urine samples. The current analysis used physical conditions that were diagnosed on the basis of the physician assessment and laboratory results. We included physical conditions only if there was previous empirical evidence of an association between anxiety disorders and the physical condition was prevalent enough to be included on the basis of power.
In the previous literature, 2 specific methods have been used to adjust for the effects of overall burden of physical illness on quality of life and service utilization: (1) a variable that counts the total number of physical conditions2,15 and (2) the Charlson Comorbidity Index (CCI).53 The latter measure was developed empirically to reliably index physical conditions that singly or in combination increase the short-term risk of mortality.54,55 All the chronic conditions assessed in the survey were given a CCI weight (from 1 to 6). A total score was computed by adding all assigned weights for each chronic condition.56,57 The CCI was significantly associated with lower mean scores on the physical component score (PCS) of the SF-36 (r = −0.42; P<.01 [2-tailed]) and with 1 or more days of disability compared with no days of disability due to physical health problems (odds ratio [OR], 1.65; 95% confidence interval [CI], 1.08-1.25). The number of physical conditions was also significantly associated with the PCS of the SF-36 (r = −0.41; P<.01 [2-tailed]) and with 1 or more days of disability compared with no days of disability due to physical health problems (OR, 1.21; 95% CI, 1.12-1.30). Thus, although either the count variable or the CCI explained a substantial proportion of variance in functional outcomes, we chose to use the more widely used CCI to adjust for overall burden of physical illness.
Assessment of Mental Disorders
The Munich Composite International Diagnostic Interview, administered by clinically trained interviewers (psychologists and physicians), was used to make lifetime, past-year, and past-month DSM-IV diagnoses.58,59 Since all quality-of-life and disability variables were from the past month, we used only past-month mental disorder diagnoses. For the current analysis, we categorized a DSM-IV anxiety disorder diagnosis based on the presence of any of the following anxiety disorders: panic disorder, agoraphobia, social phobia, simple phobia, generalized anxiety disorder, and obsessive-compulsive disorder. (Posttraumatic stress disorder was not assessed in this survey.) We also categorized a mood disorder diagnosis (major depression, dysthymia, bipolar disorders) and a substance use disorder diagnosis (alcohol and illicit substance abuse or dependence).
Assessment of Health-Related Quality of Life
The German version40,60 of the well-validated61-63 SF-36 was used.50,64,65 Eight health concepts were assessed within the past 30 days: physical functioning, social functioning, role limitations due to physical problems, bodily pain, mental health, role limitations due to emotional problems, vitality, and general health. Principal components analysis has identified 2 dimensions of the SF-36: the PCS and the mental component score (MCS).66
Similar to previous surveys,62,63 past 30-day disability was examined by the self-reported number of days of being unable to carry out usual daily activities. Parallel questions were asked for number of days of disability due to physical problems and emotional problems or use of alcohol or other drugs. Respondents were asked how many days in the prior 30 days they were totally unable to do the things they normally did. Responses ranged from 0 to 30 days. Because of the skewed nature of the responses, with most people in the community reporting 0 days of disability, a dichotomous variable was created: 0 days vs 1 or more days of disability.
Sex, age, education, and marital status were entered as covariates in the analysis. Age was treated as a continuous measure in the analysis. Education was dichotomized into either completed high school or any higher education based on the format of the German educational system. Marital status was trichotomized into (1) never married, (2) married or common-law spouse, or (3) divorced, separated, or widowed.
In all analyses, the appropriate statistical weight was used to ensure that the data were representative of the population. Standard errors were calculated using the Taylor Series Linearization method in the SUDAAN program (Research Triangle Park, NC) based on stratification information provided specifically for calculating design-based standard errors. To account for multiple comparisons, we present a more conservative P<.01, in addition to the P<.05 significance level.
We used multiple logistic regression to determine associations between anxiety disorders and individual physical conditions. Covariates in the analysis included sociodemographic factors, presence of a mood disorder, and presence of a substance use disorder. Next, using age-of-onset data available for both anxiety disorders and physical conditions, we examined the temporal order of onset of comorbid cases.
We also examined the association of comorbidity of anxiety disorders and physical health conditions with functional status: SF-36 scores and past 30-day disability. This analysis was limited to physical conditions that were significantly associated with anxiety disorders. In all regressions described herein, we included the following covariates: sociodemographic factors, mood disorder, substance use disorder, and CCI scores. Multiple linear regression was used to examine the association of comorbidity of anxiety disorders and physical illness with the PCS and MCS of the SF-36. Finally, multiple logistic regression was used to determine whether comorbidity of an anxiety disorder and a physical health condition was associated with an increased likelihood of past 30-day disability (due to emotional problems and physical conditions).
Table 1 provides the characteristics of the sample and all the independent variables and dependent variables. An anxiety disorder diagnosis was significantly associated with a mood disorder (OR, 9.64; 95% CI, 7.44-12.49) and substance use disorder (OR, 3.04; 95% CI, 2.01-4.59) diagnosis, supporting the need to adjust for the latter variables in all analyses.
Table 2 indicates that in the most stringent models, adjusting for sociodemographics and other common mental disorders, we found that the presence of an anxiety disorder was associated with respiratory diseases, gastrointestinal diseases, arthritic conditions, allergic conditions, thyroid diseases, migraine headaches, and any past-month physical condition. Table 3 indicates that across all physical conditions, most comorbid cases had the onset of the anxiety disorder before the physical conditions.
Figure 1 shows the relationship among the presence of an anxiety disorder, a physical condition, and the combination of both with the MCS and PCS of the SF-36. Importantly, the presence of a combination of anxiety disorders with any physical condition was associated with a lower mean PCS score than presence of any physical condition alone (ie, without an anxiety disorder). This finding remained statistically significant in multiple linear regression models that adjusted for sociodemographic factors, presence of mental disorders, and overall physical disease burden (as indexed by the CCI).
Table 4 indicates that for each physical condition the mean PCS score was significantly lower for those who had an anxiety disorder in addition to the physical condition. Further adjustment for mental disorders and overall physical disease burden attenuated the association for thyroid disease, arthritic conditions, and gastrointestinal disease but remained statistically significant for respiratory disease, allergies, and migraine headaches.
Figure 2 illustrates the relationship between anxiety disorders and physical conditions with 1 or more days of disability. Compared with the presence of a physical condition alone, we found that the combination of an anxiety disorder and a physical condition was associated with 1 or more days of disability due to physical illness, even after adjusting for sociodemographic factors, mood disorders, substance use disorders, and CCI scores.
Table 5 provides the proportion of respondents with 1 or more days of disability due to physical health problems for each of the physical conditions with and without anxiety disorders. Compared with respondents without anxiety disorders, the presence of an anxiety disorder was associated with 1 or more days of disability across all physical conditions. In multiple logistic regression models that adjusted for sociodemographics, other mental disorders, and CCI scores, the presence of an anxiety disorder was associated with disability for arthritic conditions and for 1 or more physical health problems.
This is the first study, to the best of our knowledge, to systematically evaluate the association between anxiety disorders and physical conditions in a large epidemiologic sample that included standardized physician-based diagnosis of physical health conditions. The current study has 3 important novel findings. First, our results demonstrated that the presence of an anxiety disorder was uniquely associated with a broad range of physician-diagnosed physical conditions. Second, the retrospective age-of-onset data suggest that the anxiety disorder preceded the onset of physical conditions among respondents with comorbidity. Third, the comorbidity of anxiety disorders with physical conditions was associated with increased likelihood of poor quality of life and disability compared with a physical condition alone. These findings extend previous work in clinical and community samples that noted an association between anxiety disorders and physical illnesses but also demonstrate the unique association of this comorbidity with poor quality of life and disability. Although there have been increased efforts to recognize and treat depression in the medically ill, our findings underscore the need to create similar programs to recognize and treat anxiety disorders in the medically ill.
In contrast to previous studies, this study was not limited by sampling biases found in treatment-seeking samples and less limited by recall biases of community surveys that have used self-report measures to assess physical illnesses. Particular strengths of the study were the use of well-established reliable measures of quality of life and disability, use of past-month variables that had the low probability of recall errors, use of clinical interviewers in the assessment of mental disorders compared with previous epidemiologic studies that used lay interviewers, and adjustment for other common mental disorders (especially depression).
Consistent with previous work, we found an association between the presence of an anxiety disorder and gastrointestinal diseases,67 respiratory diseases,12,34,68 allergic conditions,9,69 migraine headaches,15 thyroid diseases,19 and arthritic conditions.15,70 These findings underscore the importance of recognition of comorbidity of anxiety disorders among people who present with these physical health problems.
Dissimilar from previous work,34,71 the association between cardiac disease and anxiety disorders was no longer statistically significant after adjusting for comorbid depression and substance use disorders. We believe that this finding can be attributed to the low prevalence of cardiac disease (2.4%) in the current analysis, which excluded people older than 65 years. We did not find an association of anxiety disorders with hypertension and diabetes. The literature has produced inconsistent findings with regard to these associations.7,24,25,72 The difference in findings between studies is likely attributable to differences in the methods of assessment of anxiety disorders and physical health problems and the types of samples examined.
The mechanisms of association between anxiety disorders and physical conditions remain unknown, although several possibilities should be considered. First, a direct causal relationship between physical health and anxiety disorders may exist. For example, the presence of a physical illness, especially a life-threatening illness, may lead to the onset of increased anxiety and worry that reaches anxiety disorder proportions. Second, the presence of an anxiety disorder may increase the likelihood of physical illness through biological mechanisms (eg, changes in the hypothalamic-pituitary axis system or alterations in autonomic nervous system activity). Psychological mechanisms, such as anxiety sensitivity (fear of body symptoms),73,74 may be important in both maintenance of the anxiety disorder and the physical health problem. Third, an indirect mechanism might explain the relationship, in which a third variable may lead to comorbidity. For example, the presence of anxiety disorder may lead to a substance use disorder (eg, alcohol or other drug or nicotine use) that in turn leads to a physical health problem. The presence of a physical illness may lead to the use of a medication that has an adverse effect on anxiety symptoms (eg, bronchodilators in respiratory disease). Fourth, common genetic, environmental (eg, poverty, childhood adversity),75,76 and personality factors67 may explain the co-occurrence of anxiety disorders with physical health problems.
The mechanism(s) that leads to reduced quality of life and increased disability among those with comorbid anxiety disorders and physical conditions requires careful consideration. Katon et al75 present a model that poses possible mechanisms to explain the adverse impact of comorbidity of anxiety and depressive disorders with asthma. They suggest that the presence of an anxiety or depressive disorder may reduce the capacity to manage asthma and other life challenges, which may lead to decreased adherence to treatment of asthma. Decreased adherence to treatment of asthma may lead to increased asthma symptom burden and increased functional impairment. Further examination of the mechanisms that lead to increased morbidity among those with co-occurrence of anxiety and physical illness is required.
The current study has a number of limitations. First, the survey was limited to adults (aged 18-65 years); therefore, the current findings may not be generalizable to elderly and very young individuals. Second, the retrospective recall of age of onset of conditions, commonly used in cross-sectional epidemiologic surveys,77,78 may be affected by recall errors. Future longitudinal studies on this topic are warranted. Third, although the CCI was significantly associated with functional impairment and has been commonly used to adjust for the effects of medical morbidity, it is not a complete control for medical morbidity. Fourth, although physicians diagnosed the physical illnesses, certain physical illnesses are based more on self-reported data (eg, arthritis) than others (eg, diabetes). Thus, some of the associations found in the current study may be biased by overreporting of physical symptoms in anxious patients. Finally, although the respondents to the survey did not differ significantly from nonrespondents on several variables, response to the survey may nonetheless be a potential source of selection bias.
In conclusion, the current study demonstrated that anxiety disorders are uniquely associated with several physical health conditions in the community, and this comorbidity is itself associated with poorer functional outcomes. In combination with recent data demonstrating that anxiety disorders are risk factors for suicidal behavior,79 the current study suggests that anxiety disorders should be considered an important public health problem in the community. During the last decade, efforts have been substantially increased to improve recognition and treatment of depression in general practice.80 Similar efforts should be strongly considered for anxiety disorders.
Correspondence: Jitender Sareen, BSc, MD, FRCPC, PZ-430-771 Bannatyne Ave, Winnipeg, Manitoba, Canada R3E 3N4 (sareen@cc.umanitoba.ca).
Accepted for Publication: July 12, 2006.
Author Contributions:Study concept and design: Sareen, Jacobi, and Cox. Acquisition of data: Jacobi. Analysis and interpretation of data: Sareen, Jacobi, Belik, Clara, and Stein. Drafting of the manuscript: Sareen and Clara. Critical revision of the manuscript for important intellectual content: Jacobi, Cox, Belik, and Stein. Statistical analysis: Belik and Clara. Study supervision: Sareen.
Financial Disclosure: None reported.
Funding/Support: The GHS was supported by grant 01EH970/8 (German Federal Ministry of Research, Education and Science). Preparation of this article was supported by a Manitoba Health Research Council Award (Dr Sareen), by US National Institutes of Health grant MH64122 (Dr Stein), and a Canada Research Chair award (Dr Cox).
Additional Information: Mental disorders were assessed in the mental health supplement of the GHS (Max-Planck Institute of Psychiatry, Munich, Germany; principal investigator: H.-U. Wittchen) and physical conditions in the core survey of the GHS (Robert Koch Institute, Berlin, Germany; principal investigators: B.-M. Kurth, W. Thefeld). A public use file from the data set can be ordered from the second author (jacobi@psychologie.tu-dresden.de).
Acknowledgment: We thank Gregory E. Ratcliffe, BSc, and Jina Pagura, BSc, for their thoughtful review of the manuscript.
1.Frasure-Smith
NLesperance
F Depression and other psychological risks following myocardial infarction.
Arch Gen Psychiatry 2003;60627- 636
PubMedGoogle ScholarCrossref 2.Stein
MBCox
BJAfifi
TOBelik
SLSareen
J Comorbid depressive illness magnifies the impact of physical illness: a population-based perspective.
Psychol Med 2006;36587- 596
PubMedGoogle ScholarCrossref 3.Frasure-Smith
NLesperance
FGravel
GMasson
AJuneau
MBourassa
MG Long-term survival differences among low-anxious, high-anxious and repressive copers enrolled in the Montreal Heart Attack Readjustment Trial.
Psychosom Med 2002;64571- 579
PubMedGoogle Scholar 4.Thomas
JJones
GScarinci
IBrantley
P A descriptive and comparative study of the prevalence of depressive and anxiety disorders in low-income adults with type 2 diabetes and other chronic illnesses.
Diabetes Care 2003;262311- 2317
PubMedGoogle ScholarCrossref 5.Sherbourne
CDJackson
CAMeredith
LSCamp
PWells
KB Prevalence of comorbid anxiety disorders in primary care outpatients.
Arch Fam Med 1996;527- 34
PubMedGoogle ScholarCrossref 6.Weisberg
RBBruce
SEMachan
JTKessler
RCCulpepper
LKeller
MB Nonpsychiatric illness among primary care patients with trauma histories and posttraumatic stress disorder.
Psychiatr Serv 2002;53848- 854
PubMedGoogle ScholarCrossref 7.Goodwin
RDDavidson
JR Self-reported diabetes and posttraumatic stress disorder among adults in the community.
Prev Med 2005;40570- 574
PubMedGoogle ScholarCrossref 8.Goodwin
RDStein
MB Generalized anxiety disorder and peptic ulcer disease among adults in the United States.
Psychosom Med 2002;64862- 866
PubMedGoogle Scholar 11.Sherbourne
CDWells
KBJudd
LL Functioning and well-being of patients with panic disorder.
Am J Psychiatry 1996;153213- 218
PubMedGoogle Scholar 14.Honda
KGoodwin
RD Cancer and mental disorders in a national community sample: findings from the National Comorbidity Survey.
Psychother Psychosom 2004;73235- 242
PubMedGoogle ScholarCrossref 15.McWilliams
LAGoodwin
RDCox
BJ Depression and anxiety associated with three pain conditions: results from a nationally representative sample.
Pain 2004;11177- 83
PubMedGoogle ScholarCrossref 16.Kawachi
ISparrow
DVokonas
PSWeiss
ST Symptoms of anxiety and risk of coronary heart disease: the Normative Aging Study.
Circulation 1994;902225- 2229
PubMedGoogle ScholarCrossref 17.Kawachi
IColditz
GAAscherio
A
et al. Prospective study of phobic anxiety and risk of coronary heart disease in men.
Circulation 1994;891992- 1997
PubMedGoogle ScholarCrossref 18.Albert
CMChae
CURexrode
KMManson
JEKawachi
I Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women.
Circulation 2005;111480- 487
PubMedGoogle ScholarCrossref 19.Simon
NMBlacker
DKorbly
NB
et al. Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review.
J Affect Disord 2002;69209- 217
PubMedGoogle ScholarCrossref 20.Bennett
PConway
MClatworthy
JBrooke
SOwen
R Predicting post-traumatic symptoms in cardiac patients.
Heart Lung 2001;30458- 465
PubMedGoogle ScholarCrossref 21.Ginzburg
KSolomon
ZBleich
A Repressive coping style, acute stress disorder, and posttraumatic stress disorder after myocardial infarction.
Psychosom Med 2002;64748- 757
PubMedGoogle Scholar 22.Stuber
MLShemesh
ESaxe
GN Posttraumatic stress responses in children with life-threatening illnesses.
Child Adolesc Psychiatr Clin N Am 2003;12195- 209
PubMedGoogle ScholarCrossref 23.Heszen-Niejodek
IGottschalk
LAJanuszek
M Anxiety and hope during the course of three different medical illnesses: a longitudinal study.
Psychother Psychosom 1999;68304- 312
PubMedGoogle ScholarCrossref 24.Paterniti
SAlperovitch
ADucimetiere
PDealberto
MJLepine
JPBisserbe
JC Anxiety but not depression is associated with elevated blood pressure in a community group of French elderly.
Psychosom Med 1999;6177- 83
PubMedGoogle ScholarCrossref 25.Grigsby
ABAnderson
RJFreedland
KEClouse
RELustman
PJ Prevalence of anxiety in adults with diabetes: a systematic review.
J Psychosom Res 2002;531053- 1060
PubMedGoogle ScholarCrossref 26.Evers
AWKraaimaat
FWGeenen
RJacobs
JWBijlsma
JW Longterm predictors of anxiety and depressed mood in early rheumatoid arthritis: a 3 and 5 year followup.
J Rheumatol 2002;292327- 2336
PubMedGoogle Scholar 27.Segui
JRamos-Casals
MGarcia-Carrasco
M
et al. Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus: a longitudinal study of active and inactive stages of the disease.
Lupus 2000;9584- 588
PubMedGoogle ScholarCrossref 28.Rogers
MPWhite
KWarshaw
MG
et al. Prevalence of medical illness in patients with anxiety disorders.
Int J Psychiatry Med 1994;2483- 96
PubMedGoogle ScholarCrossref 29.Gillaspy
SRHoff
ALMullins
LLVan Pelt
JCChaney
JM Psychological distress in high-risk youth with asthma.
J Pediatr Psychol 2002;27363- 371
PubMedGoogle ScholarCrossref 31.Rimington
LDDavies
DHLowe
DPearson
MG Relationship between anxiety, depression, and morbidity in adult asthma patients.
Thorax 2001;56266- 271
PubMedGoogle ScholarCrossref 32.Vila
GNollet-Clemencon
Cde Blic
JMouren-Simeoni
MCScheinmann
P Prevalence of
DSM IV anxiety and affective disorders in a pediatric population of asthmatic children and adolescents.
J Affect Disord 2000;58223- 231
PubMedGoogle ScholarCrossref 33.Harter
MCConway
KPMerikangas
KR Associations between anxiety disorders and physical illness.
Eur Arch Psychiatry Clin Neurosci 2003;253313- 320
PubMedGoogle ScholarCrossref 34.Sareen
JCox
BJClara
IAsmundson
GJG The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey.
Depress Anxiety 2005;21193- 202
PubMedGoogle ScholarCrossref 35.Huovinen
EKaprio
JKoskenvuo
M Asthma in relation to personality traits, life satisfaction, and stress: a prospective study among 11,000 adults.
Allergy 2001;56971- 977
PubMedGoogle ScholarCrossref 36.Ortega
ANHuertas
SECanino
GRamirez
RRubio-Stipec
M Childhood asthma, chronic illness, and psychiatric disorders.
J Nerv Ment Dis 2002;190275- 281
PubMedGoogle ScholarCrossref 37.Ortega
ANGoodwin
RDMcQuaid
ELCanino
G Parental mental health, childhood psychiatric disorders, and asthma attacks in island Puerto Rican youth.
Ambul Pediatr 2004;4308- 315
PubMedGoogle ScholarCrossref 38.Ortega
ANMcQuaid
ELCanino
GGoodwin
RDFritz
GK Comorbidity of asthma and anxiety and depression in Puerto Rican children.
Psychosomatics 2004;4593- 99
PubMedGoogle ScholarCrossref 39.Berkson
J Limitations of application of fourfold table analysis to hospital data.
Biometrics 1946;194647- 53
Google ScholarCrossref 41.Jacobi
FWittchen
HUHolting
C
et al. Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey.
Int J Methods Psychiatr Res 2002;111- 18
PubMedGoogle ScholarCrossref 42.Edwards
WSWinn
DMKurlantzick
V
et al. Evaluation of National Health Interview Survey Diagnostic Reporting. Hyattsville, Md National Center for Health Statistics1994;
43.American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC American Psychiatric Association1994;
44.Olfson
MShea
SFeder
A
et al. Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice.
Arch Fam Med 2000;9876- 883
PubMedGoogle ScholarCrossref 45.Marcus
SCOlfson
MPincus
HAShear
MKZarin
DA Self-reported anxiety, general medical conditions, and disability bed days.
Am J Psychiatry 1997;1541766- 1768
PubMedGoogle Scholar 46.Hollifield
MKaton
WSkipper
BCTBallenger
JCMannuzza
SFyer
AJ Panic disorder and quality of life: variables predictive of functional impairment.
Am J Psychiatry 1997;154766- 772
PubMedGoogle Scholar 47.Olfson
MFireman
BWeissman
MM
et al. Mental disorders and disability among patients in a primary care group practice.
Am J Psychiatry 1997;1541734- 1740
PubMedGoogle Scholar 48.Nisenson
LGPepper
CMSchwenk
TLCoyne
JC The nature and prevalence of anxiety disorders in primary care.
Gen Hosp Psychiatry 1998;2021- 28
PubMedGoogle ScholarCrossref 49.Jacobi
FWittchen
HUHolting
C
et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS).
Psychol Med 2004;34597- 611
PubMedGoogle ScholarCrossref 50.McHorney
CAWare
JE
JrRaczek
AE The MOS 36-Item Short-Form Health Survey (SF-36), II: psychometric and clinical tests of validity in measuring physical and mental health constructs.
Med Care 1993;31247- 263
PubMedGoogle ScholarCrossref 51.Schmitz
NThefeld
WKruse
J Mental disorders and hypertension: factors associated with awareness and treatment of hypertension in the general population of Germany.
Psychosom Med 2006;68246- 252
PubMedGoogle ScholarCrossref 52.Schmitz
NKruse
JKugler
J Disabilities, quality of life, and mental disorders associated with smoking and nicotine dependence.
Am J Psychiatry 2003;1601670- 1676
PubMedGoogle ScholarCrossref 53.Charlson
MEPompei
PAles
KLMackenzie
CR A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
J Chronic Dis 1987;40373- 383
PubMedGoogle ScholarCrossref 55.Pompei
PCharlson
MEDouglas
G
Jr Clinical assessments as predictors of one year survival after hospitalization: implications for prognostic stratification.
J Clin Epidemiol 1988;41275- 284
PubMedGoogle ScholarCrossref 56.Barsky
AJOrav
EJBates
DW Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity.
Arch Gen Psychiatry 2005;62903- 910
PubMedGoogle ScholarCrossref 57.de Jonge
POrmel
Jvan den Brink
RH
et al. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis.
Am J Psychiatry 2006;163138- 144
PubMedGoogle ScholarCrossref 58.Kessler
RCÜstün
TB The World Mental Health (WMH) Survey Initiative Version of the World Health Association (WHO) Composite International Diagnostic Interview (CIDI).
Int J Methods Psychiatr Res 2004;1393- 121
PubMedGoogle ScholarCrossref 59.Wittchen
HULachner
GWunderlich
UPfister
H Test-retest reliability of the computerized
DSM-IV version of the Munich Composite International Diagnostic Interview (M-CIDI).
Soc Psychiatry Psychiatr Epidemiol 1998;33568- 578
PubMedGoogle ScholarCrossref 60.Bullinger
MAlonso
JApolone
G
et al. Translating health status questionnaires and evaluating their quality: the IQOLA Project approach.
J Clin Epidemiol 1998;51913- 923
PubMedGoogle ScholarCrossref 61.Hopman
WMTowheed
TAnastassiades
T
et al. Canadian normative data for the SF-36 Health Survey.
CMAJ 2000;163265- 271
PubMedGoogle Scholar 62.Kessler
RCOrmel
JDemler
OStang
PE Comorbid mental disorders account for the role impairment of commonly occurring chronic physical disorders: results from the National Comorbidity Survey.
J Occup Environ Med 2003;451257- 1266
PubMedGoogle ScholarCrossref 63.Sareen
JStein
MBCox
BJHassard
ST Understanding comorbidity of anxiety disorders and antisocial behavior: findings from two large community surveys.
J Nerv Ment Dis 2004;192178- 186
PubMedGoogle ScholarCrossref 64.Stewart
ALHays
RDWare
JE The MOS Short-Form General Health Survey: reliability and validity in a patient population.
Med Care 1988;26724- 732
PubMedGoogle ScholarCrossref 65.McHorney
CAWare
JE
JrLu
JFRSherbourne
CD The MOS 36-Item Short-Form Health Survey (SF-36), III: tests of data quality, scaling assumptions, and reliability across diverse patient groups.
Med Care 1994;3240- 66
PubMedGoogle ScholarCrossref 66.Ware
JE
JrKosinski
MGandek
B
et al. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project: International Quality of Life Assessment.
J Clin Epidemiol 1998;511159- 1165
PubMedGoogle ScholarCrossref 67.Goodwin
RDStein
MB Peptic ulcer disease and neuroticism in the United States adult population.
Psychother Psychosom 2003;7210- 15
PubMedGoogle ScholarCrossref 69.Kovalenko
PAHoven
CWWu
PWicks
JMandell
DJTiet
Q Association between allergy and anxiety disorders in youth.
Aust N Z J Psychiatry 2001;35815- 821
PubMedGoogle ScholarCrossref 70.McWilliams
LACox
BJEnns
MW Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample.
Pain 2003;106127- 133
PubMedGoogle ScholarCrossref 71.Roose
SP Depression, anxiety, and the cardiovascular system: the psychiatrist's perspective.
J Clin Psychiatry 2001;62
((suppl 8))
19- 22
PubMedGoogle ScholarCrossref 73.Goodwin
RDHoven
CWMurison
RHotopf
M Association between childhood physical abuse and gastrointestinal disorders and migraine in adulthood.
Am J Public Health 2003;931065- 1067
PubMedGoogle ScholarCrossref 74.Goodwin
RDStein
MB Association between childhood trauma and physical disorders among adults in the United States.
Psychol Med 2004;34509- 520
PubMedGoogle ScholarCrossref 75.Katon
WJRichardson
LLozano
PMcCauley
E The relationship of asthma and anxiety disorders.
Psychosom Med 2004;66349- 355
PubMedGoogle Scholar 76.Kessler
RCChiu
WTDemler
OWalters
EE Prevalence, severity, and comorbidity of 12-month
DSM-IV disorders in the National Comorbidity Survey Replication.
Arch Gen Psychiatry 2005;62617- 627
PubMedGoogle ScholarCrossref 77.Kessler
RCBorges
GWalters
EE Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey.
Arch Gen Psychiatry 1999;56617- 626
PubMedGoogle ScholarCrossref 78.Kessler
RCStang
PWittchen
H-UStein
MBWalters
EE Lifetime comorbidities between social phobia and mood disorders in the U.S. National Comorbidity Survey.
Psychol Med 1999;29555- 567
PubMedGoogle ScholarCrossref 79.Sareen
JCox
BJAfifi
TO
et al. Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults.
Arch Gen Psychiatry 2005;621249- 1257
PubMedGoogle ScholarCrossref 80.Pignone
MPGavnes
BNRushton
JL
et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force.
Ann Intern Med 2002;136765- 776
PubMedGoogle ScholarCrossref